title: Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation.
authors.forename: Takayoshi
authors.initials: T
authors.lastname: Tachibana
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Tanaka
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Takasaki
authors.forename: Ayumi
authors.initials: A
authors.lastname: Numata
authors.forename: Shin
authors.initials: S
authors.lastname: Fujisawa
authors.forename: Atsuo
authors.initials: A
authors.lastname: Maruta
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Harada
authors.forename: Hiraku
authors.initials: H
authors.lastname: Mori
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Ishigatsubo
authors.forename: Heiwa
authors.initials: H
authors.lastname: Kanamori
mesh_terms: D019264:Adoptive Transfer; D000328:Adult; D000617:Aminoglycosides / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D000079982:Gemtuzumab; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000628:therapy*; D012008:Recurrence; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000079982:Gemtuzumab